Pathologica LLC
14Patents
13Active
14Granted
46Portfolio score
Filing activity: Nov 18, 2002 → Aug 23, 2018 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8258186B2 | Pharmaceutical for oral delivery comprising MGBG | Human Necessities | 12 | Active |
| US7198946B2 | Screening for agents effective in decreasing abnormal macrophages associated with amyotrophic lateral sclerosis | Physics | 11 | Expired |
| US8445540B2 | Regulation of osteopontin | Human Necessities | 9 | Active |
| US7879914B2 | Methods for treating viral infections using polyamine analogs | Human Necessities | 8 | Active |
| US8858991B2 | Delayed release oral pharmaceutical dosage forms comprising MGBG | Chemistry; Metallurgy | 8 | Active |
| US9675566B2 | Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing | Human Necessities | 4 | Active |
| US9867794B2 | Regulation of osteopontin | Human Necessities | 3 | Active |
| US9668988B2 | Controlled release oral pharmaceutical dosage forms comprising MGBG | Chemistry; Metallurgy | 3 | Active |
| US10292950B2 | Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing | Human Necessities | 2 | Active |
| US10350178B2 | Methods and compositions for treatment of demyelinating diseases | Human Necessities | 1 | Active |
| US10085955B2 | Methods and compositions for treatment of demyelinating diseases | Human Necessities | 1 | Active |
| US8198334B2 | Methods for modulating macrophage proliferation in ocular disease using polyamine analogs | Physics | 0 | Active |
| US10881626B2 | Controlled release oral pharmaceutical dosage forms comprising MGBG | Chemistry; Metallurgy | 0 | Active |
| US9616035B2 | Pharmaceutical for oral delivery comprising MGBG and methods of treating disease | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.